retatrutide type 2 diabetes phase 2 trial hba1c Effects of retatrutide, dulaglutide, and placebo on gastric emptying in Advancements in Clinical Research and

Or VO2 max

Quick Answer: While taking Zepbound, patients should avoid high-fat and greasy foods, certain medication combinations (especially other GLP-1 agonists and weight-loss products), excessive alcohol, and extreme caloric restriction to optimize treatment safety and effectiveness

According to the American Diabetes Association (ADA) Standards of Care, GLP-1 receptor agonists with proven cardiovascular benefit are recommended for many patients with type 2 diabetes who have established cardiovascular disease, with individualized therapy based on patient factors

Our team at The Peer Group will continue to monitor and evaluate each patients progress all while providing ongoing support and monitoring throughout their weight loss journey